Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $26.34 in the prior trading day, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $25.10, down -4.71%. In other words, the price has decreased by -$4.71 from its previous closing price. On the day, 1.35 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BEAM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
On November 06, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $27 to $39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 18 ’25 when Cavanagh Bethany J sold 6,287 shares for $35.00 per share. The transaction valued at 220,045 led to the insider holds 37,527 shares of the business.
Bellon Christine sold 10,000 shares of BEAM for $340,000 on Feb 14 ’25. The Chief Legal Officer now owns 102,968 shares after completing the transaction at $34.00 per share. On Feb 14 ’25, another insider, CHRISTINE BELLON, who serves as the Officer of the company, bought 10,000 shares for $34.00 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 33.07 while its Price-to-Book (P/B) ratio in mrq is 2.86.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $45.05, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -7.62%, while the 200-Day Moving Average is calculated to be -2.47%.
Shares Statistics:
A total of 83.63M shares are outstanding, with a floating share count of 73.69M. Insiders hold about 11.95% of the company’s shares, while institutions hold 83.37% stake in the company.
